CorVel Corporation's SEC filings document the company's public-company reporting for a technology-enabled risk management business serving workers' compensation and health, auto, and liability programs. Recent 8-K filings furnish quarterly financial results through Item 2.02 disclosures and related earnings press releases.
CorVel's proxy and annual meeting filings cover stockholder voting matters, director elections, auditor ratification, and governance procedures. The filings also identify the company's common stock, par value $0.0001 per share, traded under CRVL on the Nasdaq Global Select Market, tying its governance record to its listed equity security.
CorVel Corp director Steven J. Hamerslag received a grant of 1,500 Non-Qualified Stock Options on August 6, 2026. The options carry an exercise price of $62.45 per share and are exercisable in four equal annual installments beginning 12 months after the grant date, expiring on August 6, 2036. Following this grant, he holds options for 1,500 underlying shares directly.
CorVel Corp CEO & President Michael G. Combs received a grant of 1,500 Non-Qualified Stock Options on August 6, 2026. The options have an exercise price of $62.45 per share, relate to 1,500 shares of common stock, and expire on August 6, 2036. According to the footnote, they become exercisable in four equal annual installments starting 12 months after the grant date, and are held as a direct ownership position.
CORVEL CORP reported that director Joanna M. Burkey received a grant of 1,500 Non-Qualified Stock Options on 2026-08-06. The options carry an exercise price of $62.45 per share and expire on 2036-08-06. According to the terms, they become exercisable in four equal annual installments starting 12 months after the grant date. Following this grant, Burkey holds 1,500 options directly.
CorVel Corporation reported higher managed care results for the quarter ended June 30, 2026, with revenue of $259.9 million, up 10.7% year over year. Net income rose to $32.2 million, and diluted earnings per share increased to $0.63 from $0.52.
Gross margin improved to 26.1% as both patient management revenue ($159.3 million) and network solutions revenue ($100.6 million) grew, aided by more claims and enhanced bill review activity. Operating cash flow was $49.9 million, and cash and equivalents reached $255.9 million.
The company repurchased 377,098 shares for approximately $21.8 million, leaving 50.6 million shares outstanding at June 30, 2026. Leadership changed on July 1, 2026, as Sarah A. Scott became Chief Executive Officer and President, with former CEO Michael G. Combs transitioning to Executive Chair. Management highlights competition, inflationary pressures, and technology disruption as key ongoing risks.
CorVel Corp Chief Financial Officer Brian S. Nichols exercised a non-qualified stock option for 51 shares of common stock on 2026-08-04 at an exercise price of $52.647 per share. The option, which was exercisable in tranches and set to expire on 2026-08-05, was fully exercised, and 46 shares of common stock were delivered at $59.10 per share to satisfy the option exercise price and/or related tax liability.
CorVel Corporation reported results for the quarter ended June 30, 2026. Revenues were $259,925,000, compared with $234,711,000 a year earlier. Gross profit was $67,794,000 at a 26% gross margin, compared with $56,761,000, and income from operations was $43,341,000 versus $35,283,000. Net income totaled $32,225,000, with basic and diluted earnings per share of $0.63 compared with $0.53 basic and $0.52 diluted in the prior-year quarter.
The company reported cash and cash equivalents of $255,883,000 and no borrowings at June 30, 2026, and repurchased $21.8 million of common stock during the quarter. Total assets were $689,735,000, supported by retained earnings of $1,045,654,000. Management highlighted ongoing investments in technology-enabled services, including new Executive Advisory Services for workers’ compensation and liability clients and expanded payment integrity capabilities through CERIS.
Director Alan Hoops of CorVel Corp exercised 9,000 Non-Qualified Stock Options into Common Stock on 2026-07-31 at an exercise price of $14.44 per share. This raised his direct Common Stock holdings to 33,192 shares.
An additional 113,713 Common Stock shares are reported as held indirectly through the Hoops Irrevocable Trust.
CorVel executive Mark E. Bertels exercised 750 non-qualified stock options on July 29, 2026 at $52.647 per share, receiving common stock. To pay the option exercise price and/or related tax obligations, 667 common shares were delivered or withheld at $62.25 per share. The reported option grant is now fully exercised.
CorVel Corp CEO Sarah A. Scott received a grant of 25,000 non-qualified stock options on July 1, 2026. The options have an exercise price of $64.49 per share, expire on July 1, 2031, and vest 25% one year after grant, with the remaining shares vesting in 36 equal monthly installments. Following this award, 25,000 options are reported as held directly under this grant.
CorVel Corp (CRVL) reports that CEO and President Sarah A. Scott holds several direct non-qualified stock options to purchase CorVel common stock. The positions cover different grants with exercise prices between $49.6300 and $110.1800 and expirations from 2027 through 2031. Footnotes state that some options vest 25% one year after grant with the remainder in 36 monthly installments, and others vest based on achieving earnings-growth performance criteria.